Understanding the problem of chronic kidney disease in the Republic of Kazakhstan: the study on prevalence and patients' health behaviors - Report - MDSpire

Understanding the problem of chronic kidney disease in the Republic of Kazakhstan: the study on prevalence and patients' health behaviors

  • By

  • Yerlan Burkutov

  • Yernur Zikiriya

  • Olzhas Zhandossov

  • Dinara Makhanbetkulova

  • June 3, 2026

  • 0 min

Share

Clinical Report: Examining Chronic Kidney Disease Prevalence in Kazakhstan

Overview

This study analyzes the prevalence of chronic kidney disease (CKD) and hemodialysis in Kazakhstan from 2017 to 2019, revealing significant regional variations and a concerning lack of patient knowledge regarding their condition. The findings highlight the need for improved health literacy and self-management among CKD patients.

Background

Chronic kidney disease (CKD) is a major public health issue, particularly in low- and middle-income countries like Kazakhstan, where epidemiological data is scarce. Understanding CKD prevalence and patient health behaviors is crucial for developing effective healthcare policies and interventions. This study addresses the knowledge gap regarding CKD in Kazakhstan, emphasizing the importance of health literacy and self-management in patient outcomes.

Data Highlights

{'2019': {'CKD Prevalence': 'Provide actual data or clarify if it was not measured.'}}

Key Findings

  • The highest point prevalence of CKD was observed in Turkestan province at 388.8 PMP in 2017.
  • The point prevalence of hemodialysis exceeded that of CKD, with a maximum of 629.3 PMP in Kostanay province in 2018.
  • There was a general increase in hemodialysis prevalence across provinces over the study period, except in Kostanay.
  • CKD patients demonstrated suboptimal disease knowledge and self-management skills, with notable gender-specific differences.
  • The study underscores the urgent need for enhanced health education and management strategies for CKD patients in Kazakhstan.

Clinical Implications

Healthcare providers should prioritize improving health literacy and self-management skills among CKD patients to enhance their understanding of the disease and treatment options. Implementing targeted educational interventions may help mitigate the rising prevalence of CKD and its complications in Kazakhstan.

Conclusion

The findings of this study highlight significant regional disparities in CKD and hemodialysis prevalence in Kazakhstan, alongside a critical need for improved patient education and self-management strategies. Further research is essential to address these gaps and inform healthcare policy.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Patient Awareness, Attitudes, and Practices Regarding Osteosarcopenia in Chronic Kidney Disease: A Cross-Sectional Study
  2. JAMA Network Open, 2025 -- Clinical Decision Support for Chronic Kidney Disease in Primary Care: A Cluster Randomized Clinical Trial
  3. DIGITAL HEALTH, 2025 -- Artificial intelligence in chronic kidney disease: Bibliometric and visual analysis of trends and future directions
  4. The Journal of Clinical Endocrinology & Metabolism -- Impact of Female Reproductive Health and Hormonal Treatments on the Development of Chronic Kidney Disease and End-Stage Renal Disease
  5. KDIGO, 2024 -- KDIGO 2024 CKD Guideline
  6. New England Journal of Medicine -- Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
  7. S U P P L E M E N T TO
  8. Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease | New England Journal of Medicine
  9. Type of the Paper (Article

Original Source(s)

Related Content